Semin Thromb Hemost 2018; 44(08): 723-733
DOI: 10.1055/s-0038-1673625
Review Aritcle
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Acquired and Genetic Thrombotic Risk Factors in the Athlete

Emma Kate Zadow
1   School of Health Sciences, Sports Performance Optimisation Research Team, University of Tasmania, Tasmania, Australia
,
Murray John Adams
1   School of Health Sciences, Sports Performance Optimisation Research Team, University of Tasmania, Tasmania, Australia
2   School of Veterinary and Life Sciences, Murdoch University, Murdoch, Western Australia
,
Cecilia M. Kitic
1   School of Health Sciences, Sports Performance Optimisation Research Team, University of Tasmania, Tasmania, Australia
,
Sam Shi Xuan Wu
1   School of Health Sciences, Sports Performance Optimisation Research Team, University of Tasmania, Tasmania, Australia
3   Department of Health and Medical Sciences, Swinburne University of Technology, Hawthorn, Victoria, Australia
,
James William Fell
1   School of Health Sciences, Sports Performance Optimisation Research Team, University of Tasmania, Tasmania, Australia
› Author Affiliations
Further Information

Publication History

Publication Date:
04 October 2018 (online)

Abstract

While athletes are often considered the epitome of health due to their physique and lowered potential for metabolic and cardiovascular diseases, they may also be at risk for the onset and development of venous thromboembolism (VTE). In an attempt to achieve and remain competitive, athletes are frequently exposed to numerous athlete-specific risk factors, which may predispose them to VTE through the disruption of factors associated with Virchow's triad (i.e., hypercoagulability, venous stasis, and vessel wall injury). Indeed, hypercoagulability within an athletic population has been well documented to occur due to a combination of multiple factors including exercise, dehydration, and polycythemia. Furthermore, venous stasis within an athletic population may occur as a direct result of prolonged periods of immobilization experienced when undertaking long-distance travels for training and competition, recovery from injury, and overdevelopment of musculature. While all components of Virchow's triad are disrupted, injury to the vessel wall has emerged as the most important factor contributing to thrombosis formation within an athletic population, due to its ability to influence multiple hemostatic mechanisms. Vessel wall injury within an athletic population is often related to repetitive microtrauma to the venous and arterial walls as a direct result of sport-dependent trauma, in addition to high metabolic rates and repetitive blood monitoring. Although disturbances to Virchow's triad may not be detrimental to most individuals, approximately 1 in 1,000 athletes will experience a potentially fatal post-exercise thrombotic incidence. When acquired factors are considered in conjunction with genetic predispositions to hypercoagulability present in some athletes, an overall increased risk for VTE is present.

 
  • References

  • 1 Lee IM, Sesso HD, Oguma Y, Paffenbarger Jr RS. Relative intensity of physical activity and risk of coronary heart disease. Circulation 2003; 107 (08) 1110-1116
  • 2 Kahn SR, Shrier I, Kearon C. Physical activity in patients with deep venous thrombosis: a systematic review. Thromb Res 2008; 122 (06) 763-773
  • 3 Smith JE. Effects of strenuous exercise on haemostasis. Br J Sports Med 2003; 37 (05) 433-435
  • 4 Gunga HC, Kirsch K, Beneke R. , et al. Markers of coagulation, fibrinolysis and angiogenesis after strenuous short-term exercise (Wingate-test) in male subjects of varying fitness levels. Int J Sports Med 2002; 23 (07) 495-499
  • 5 Prisco D, Paniccia R, Bandinelli B. , et al. Evaluation of clotting and fibrinolytic activation after protracted physical exercise. Thromb Res 1998; 89 (02) 73-78
  • 6 Weiss C, Welsch B, Albert M. , et al. Coagulation and thrombomodulin in response to exercise of different type and duration. Med Sci Sports Exerc 1998; 30 (08) 1205-1210
  • 7 Kestin AS, Ellis PA, Barnard MR, Errichetti A, Rosner BA, Michelson AD. Effect of strenuous exercise on platelet activation state and reactivity. Circulation 1993; 88 (4, Pt 1): 1502-1511
  • 8 Hansen JB, Wilsgård L, Olsen JO, Osterud B. Formation and persistence of procoagulant and fibrinolytic activities in circulation after strenuous physical exercise. Thromb Haemost 1990; 64 (03) 385-389
  • 9 Molz AB, Heyduck B, Lill H, Spanuth E, Röcker L. The effect of different exercise intensities on the fibrinolytic system. Eur J Appl Physiol Occup Physiol 1993; 67 (04) 298-304
  • 10 Posthuma JJ, van der Meijden PE, Ten Cate H, Spronk HM. Short- and Long-term exercise induced alterations in haemostasis: a review of the literature. Blood Rev 2015; 29 (03) 171-178
  • 11 El-Sayed MS, El-Sayed Ali Z, Ahmadizad S. Exercise and training effects on blood haemostasis in health and disease: an update. Sports Med 2004; 34 (03) 181-200
  • 12 Hilberg T, Jeschke D, Gabriel HH. Hereditary thrombophilia in elite athletes. Med Sci Sports Exerc 2002; 34 (02) 218-221
  • 13 Siahkouhian M, Khodadadi D, Bolboli L. Diurnal variation of haemostatic response to exercise in young sedentary males. Biol Sport 2013; 30 (02) 125-130
  • 14 Zadow EK, Kitic CM, Wu SSX, Fell JW, Adams MJ. Time of day and short-duration high-intensity exercise influences on coagulation and fibrinolysis. Eur J Sport Sci 2018; 18 (03) 367-375
  • 15 Pinotti M, Bertolucci C, Portaluppi F. , et al. Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity. Arterioscler Thromb Vasc Biol 2005; 25 (03) 646-649
  • 16 Aldemir H, Kiliç N. The effect of time of day and exercise on platelet functions and platelet-neutrophil aggregates in healthy male subjects. Mol Cell Biochem 2005; 280 (1-2): 119-124
  • 17 Kapiotis S, Jilma B, Quehenberger P, Ruzicka K, Handler S, Speiser W. Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex. Circulation 1997; 96 (01) 19-21
  • 18 Dahlbäck B. Factor V gene mutation causing inherited resistance to activated protein C as a basis for venous thromboembolism. J Intern Med 1995; 237 (03) 221-227
  • 19 Allana AM, Teo LL, Chuah BY, Liu TC, Cheah WK. Effort thrombosis in a young triathlete: an unusual presentation of painless neck swelling secondary to right brachiocephalic vein thrombosis. Singapore Med J 2011; 52 (03) e37-e39
  • 20 Hull CM, Hopkins CL, Purdy NJ, Lloyd RC, Harris JA. A case of unprovoked venous thromboembolism in a marathon athlete presenting atypical sequelae: what are the chances?. Scand J Med Sci Sports 2015; 25 (05) 699-705
  • 21 Theiss JL, Fink ML, Gerber JP. Deep vein thrombosis in a young marathon athlete. J Orthop Sports Phys Ther 2011; 41 (12) 942-947
  • 22 Sanz de la Garza M, Lopez A, Sitges M. Multiple pulmonary embolisms in a male marathon athlete: Is intense endurance exercise a real thrombogenic risk?. Scand J Med Sci Sports 2017; 27 (05) 563-566
  • 23 Meyering C, Howard T. Hypercoagulability in athletes. Curr Sports Med Rep 2004; 3 (02) 77-83
  • 24 Zivelin A, Rosenberg N, Faier S. , et al. A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood 1998; 92 (04) 1119-1124
  • 25 Rosendaal FR. Venous thrombosis: prevalence and interaction of risk factors. Haemostasis 1999; 29 (Suppl S1): 1-9
  • 26 Grabowski G, Whiteside WK, Kanwisher M. Venous thrombosis in athletes. J Am Acad Orthop Surg 2013; 21 (02) 108-117
  • 27 Dahlbäck B. Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood 2008; 112 (01) 19-27
  • 28 El-Sayed MS, Sale C, Jones PG, Chester M. Blood hemostasis in exercise and training. Med Sci Sports Exerc 2000; 32 (05) 918-925
  • 29 Herren T, Bärtsch P, Haeberli A, Straub PW. Increased thrombin-antithrombin III complexes after 1 h of physical exercise. J Appl Physiol (1985) 1992; 73 (06) 2499-2504
  • 30 Millar-Craig MW, Bishop CN, Raftery EB. Circadian variation of blood-pressure. Lancet 1978; 1 (8068): 795-797
  • 31 el-Sayed MS. Effects of exercise on blood coagulation, fibrinolysis and platelet aggregation. Sports Med 1996; 22 (05) 282-298
  • 32 Bärtsch P, Haeberli A, Straub PW. Blood coagulation after long distance running: antithrombin III prevents fibrin formation. Thromb Haemost 1990; 63 (03) 430-434
  • 33 Dufaux B, Order U, Liesen H. Effect of a short maximal physical exercise on coagulation, fibrinolysis, and complement system. Int J Sports Med 1991; 12 (Suppl. 01) S38-S42
  • 34 Wall BA, Watson G, Peiffer JJ, Abbiss CR, Siegel R, Laursen PB. Current hydration guidelines are erroneous: dehydration does not impair exercise performance in the heat. Br J Sports Med 2015; 49 (16) 1077-1083
  • 35 Fellmann N. Hormonal and plasma volume alterations following endurance exercise. A brief review. Sports Med 1992; 13 (01) 37-49
  • 36 Casa DJ, Armstrong LE, Hillman SK. , et al. National athletic trainers' association position statement: fluid replacement for athletes. J Athl Train 2000; 35 (02) 212-224
  • 37 Ertl AC, Bernauer EM, Hom CA. Plasma volume shifts with immersion at rest and two exercise intensities. Med Sci Sports Exerc 1991; 23 (04) 450-457
  • 38 Whittlesey MJ, Maresh CM, Armstrong LE. , et al. Plasma volume responses to consecutive anaerobic exercise tests. Int J Sports Med 1996; 17 (04) 268-271
  • 39 Berglund B. High-altitude training. Aspects of haematological adaptation. Sports Med 1992; 14 (05) 289-303
  • 40 Svedenhag J, Saltin B, Johansen C, Kaijser L. Aerobic and anaerobic exercise capacities of elite middle-distance runners after two weeks of training at moderate altitudes. Scand J Med Sci Sports 1991; 1: 205-214
  • 41 Pigman EC. Acute mountain sickness. Effects and implications for exercise at intermediate altitudes. Sports Med 1991; 12 (02) 71-79
  • 42 Berglund B, Birgegård G, Hemmingsson P. Serum erythropoietin in cross-country skiers. Med Sci Sports Exerc 1988; 20 (02) 208-209
  • 43 Otterstetter R, Szymanski LM, Kamimori GH, Kessler CM, Gold MR, Fernhall B. Hemostatic responses to maximal exercise in oral contraceptive users. Am J Obstet Gynecol 1999; 181 (04) 958-963
  • 44 Apgar BS, Kaufman AH, George-Nwogu U, Kittendorf A. Treatment of menorrhagia. Am Fam Physician 2007; 75 (12) 1813-1819
  • 45 Rosendaal FR, Van Hylckama Vlieg A, Tanis BC, Helmerhorst FM. Estrogens, progestogens and thrombosis. J Thromb Haemost 2003; 1 (07) 1371-1380
  • 46 Farmer RD, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR. Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Lancet 1997; 349 (9045): 83-88
  • 47 Tans G, Curvers J, Middeldorp S. , et al. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways. Thromb Haemost 2000; 84 (01) 15-21
  • 48 Winkler UH, Schindler AE, Endrikat J, Düsterberg B. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol. Contraception 1996; 53 (02) 75-84
  • 49 Lidegaard Ø, Edström B, Kreiner S. Oral contraceptives and venous thromboembolism: a five-year national case-control study. Contraception 2002; 65 (03) 187-196
  • 50 Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344 (8935): 1453-1457
  • 51 Ferenchick GS. Anabolic/androgenic steroid abuse and thrombosis: is there a connection?. Med Hypotheses 1991; 35 (01) 27-31
  • 52 Lage JM, Panizo C, Masdeu J, Rocha E. Cyclist's doping associated with cerebral sinus thrombosis. Neurology 2002; 58 (04) 665
  • 53 Deligiannis A, Björnstad H, Carre F. , et al; ESC Study Group of Sports Cardiology. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes. Eur J Cardiovasc Prev Rehabil 2006; 13 (05) 687-694
  • 54 McNutt RA, Ferenchick GS, Kirlin PC, Hamlin NJ. Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol 1988; 62 (01) 164
  • 55 Uzunova AD, Ramey ER, Ramwell PW. Arachidonate-induced thrombosis in mice: effects of gender or testosterone and estradiol administration. Prostaglandins 1977; 13 (05) 995-1002
  • 56 Deguchi K, Noguchi M, Yuwasaki E. , et al. Dynamic fluctuations in blood of thrombin/antithrombin III complex (TAT). Am J Hematol 1991; 38 (02) 86-89
  • 57 Chang S, Münster A-MB, Gram J, Johannes J, Sidelmann JJ. Anabolic androgenic steroid abuse: the effects on thrombosis risk, coagulation, and fibrinolysis. 2018; 44 (08) 734-746
  • 58 Weiss C, Seitel G, Bärtsch P. Coagulation and fibrinolysis after moderate and very heavy exercise in healthy male subjects. Med Sci Sports Exerc 1998; 30 (02) 246-251
  • 59 Kleinegris MC, Ten Cate-Hoek AJ, Ten Cate H. Coagulation and the vessel wall in thrombosis and atherosclerosis. Pol Arch Med Wewn 2012; 122 (11) 557-566
  • 60 Aziz S, Straehley CJ, Whelan Jr TJ. Effort-related axillosubclavian vein thrombosis. A new theory of pathogenesis and a plea for direct surgical intervention. Am J Surg 1986; 152 (01) 57-61
  • 61 Shebel ND, Marin A. Effort thrombosis (Paget-Schroetter syndrome) in active young adults: current concepts in diagnosis and treatment. J Vasc Nurs 2006; 24 (04) 116-126
  • 62 Roche-Nagle G, Ryan R, Barry M, Brophy D. Effort thrombosis of the upper extremity in a young sportsman: Paget-Schroetter syndrome. Br J Sports Med 2007; 41 (08) 540-541 , discussion 541
  • 63 Echlin PS, Upshur RE, McKeag DB, Jayatilake HP. Traumatic deep vein thrombosis in a soccer player: a case study. Thromb J 2004; 2 (01) 8
  • 64 Para I, Leach N, Negrean V, Alexescu T. Venous pathology in athletes. Palestrica of the Third Millennium—Civilization and Sport 2015 ;16(4):351–354
  • 65 van Stralen KJ, Blom JW, Doggen CJ, Rosendaal FR. Strenuous sport activities involving the upper extremities increase the risk of venous thrombosis of the arm. J Thromb Haemost 2005; 3 (09) 2110-2111
  • 66 van Stralen KJ, Rosendaal FR, Doggen CJM. Minor injuries as a risk factor for venous thrombosis. Arch Intern Med 2008; 168 (01) 21-26
  • 67 Knudson MM, Collins JA, Goodman SB, McCrory DW. Thromboembolism following multiple trauma. J Trauma 1992; 32 (01) 2-11
  • 68 Durham JR, Yao JS, Pearce WH, Nuber GM, McCarthy III WJ. Arterial injuries in the thoracic outlet syndrome. J Vasc Surg 1995; 21 (01) 57-69 , discussion 70
  • 69 Leon M, Volteas N, Labropoulos N. , et al. Popliteal vein entrapment in the normal population. Eur J Vasc Surg 1992; 6 (06) 623-627
  • 70 Boden BP, Breit I, Beachler JA, Williams A, Mueller FO. Fatalities in high school and college football players. Am J Sports Med 2013; 41 (05) 1108-1116
  • 71 Adams M, Williams A, Fell J. Exercise in the fight against thrombosis: friend or foe?. Semin Thromb Hemost 2009; 35 (03) 261-268
  • 72 Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton III LJ. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000; 160 (06) 809-815
  • 73 Anderson Jr FA, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003; 107 (23) (Suppl. 01) I9-I16
  • 74 Lindberg F, Rasmussen I, Siegbahn A, Bergqvist D. Coagulation activation after laparoscopic cholecystectomy in spite of thromboembolism prophylaxis. Surg Endosc 2000; 14 (09) 858-861
  • 75 Ellison GM, Waring CD, Vicinanza C, Torella D. Physiological cardiac remodelling in response to endurance exercise training: cellular and molecular mechanisms. Heart 2012; 98 (01) 5-10
  • 76 Hull CM, Harris JA. Cardiology patient page. Venous thromboembolism and marathon athletes. Circulation 2013; 128 (25) e469-e471
  • 77 Hirokawa M, Iwai T, Inoue Y, Sato S. Surgical treatment of popliteal vein entrapment causing symptoms. Phlebology 2002; 17 (3–4): 103-107
  • 78 Perlowski AA, Jaff MR. Vascular disorders in athletes. Vasc Med 2010; 15 (06) 469-479
  • 79 Arko FR, Harris EJ, Zarins CK, Olcott IV C. Vascular complications in high-performance athletes. J Vasc Surg 2001; 33 (05) 935-942
  • 80 Kommareddy A, Zaroukian MH, Hassouna HI. Upper extremity deep venous thrombosis. Semin Thromb Hemost 2002; 28 (01) 89-99
  • 81 Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Old and new risk factors for upper extremity deep venous thrombosis. J Thromb Haemost 2005; 3 (11) 2471-2478
  • 82 May R, Thurner J. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology 1957; 8 (05) 419-427
  • 83 Bartholomew JR, Schaffer JL, McCormick GF. Air travel and venous thromboembolism: minimizing the risk. Cleve Clin J Med 2011; 78 (02) 111-120
  • 84 Parker B, Augeri A, Capizzi J. , et al. Effect of air travel on exercise-induced coagulatory and fibrinolytic activation in marathon runners. Clin J Sport Med 2011; 21 (02) 126-130
  • 85 Lippi G, Favaloro EJ. Car travel-related thrombosis: fact or fiction?. Semin Thromb Hemost 2018; 44 (04) 327-333
  • 86 Izadi M, Alemzadeh-Ansari MJ, Kazemisaleh D, Jonidi N. Venous thromboembolism following travel. Int J Travel Med Glob Health 2014; 2 (01) 23-30
  • 87 Tao K, Davenport M. Deep venous thromboembolism in a triathlete. J Emerg Med 2010; 38 (03) 351-353
  • 88 Moyses C, Cederholm-Williams SA, Michel CC. Haemoconcentration and accumulation of white cells in the feet during venous stasis. Int J Microcirc Clin Exp 1987; 5 (04) 311-320
  • 89 Schreijer AJ, Cannegieter SC, Meijers JC, Middeldorp S, Büller HR, Rosendaal FR. Activation of coagulation system during air travel: a crossover study. Lancet 2006; 367 (9513): 832-838
  • 90 Kupchak BR. Exercise and Air-Travel Induced Alterations in Blood Hemostasis. 2018; 44 (08) 756-764
  • 91 De Caterina M, Grimaldi E, Passaretti M. , et al. Four cases of venous thrombosis in athletes with silent hereditary defects of the protein C system. Thromb Haemost 2005; 94 (02) 463-464
  • 92 Crowther MA, Kelton JG. Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system. Ann Intern Med 2003; 138 (02) 128-134
  • 93 Angleton P, Chandler WL, Schmer G. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation 1989; 79 (01) 101-106
  • 94 Casale G, Butte' M, Pasotti C, Ravecca D, De Nicola P. Antithrombin III and circadian rhythms in the aged and in myocardial infarction. Haematologica 1983; 68 (05) 615-619
  • 95 Grimaudo V, Hauert J, Bachmann F, Kruithof EK. Diurnal variation of the fibrinolytic system. Thromb Haemost 1988; 59 (03) 495-499
  • 96 Szymanski LM, Pate RR. Effects of exercise intensity, duration, and time of day on fibrinolytic activity in physically active men. Med Sci Sports Exerc 1994; 26 (09) 1102-1108
  • 97 Szymanski LM, Pate RR. Fibrinolytic responses to moderate intensity exercise. Comparison of physically active and inactive men. Arterioscler Thromb 1994; 14 (11) 1746-1750
  • 98 Asano H, Matsubara M, Suzuki K, Morita S, Shinomiya K. Prevention of pulmonary embolism by a foot sole pump. J Bone Joint Surg Br 2001; 83 (08) 1130-1132
  • 99 Agu O, Hamilton G, Baker D. Graduated compression stockings in the prevention of venous thromboembolism. Br J Surg 1999; 86 (08) 992-1004
  • 100 Brennan MJ, Miller LT. Overview of treatment options and review of the current role and use of compression garments, intermittent pumps, and exercise in the management of lymphedema. Cancer 1998; 83 (12, Suppl American): 2821-2827
  • 101 Földi E. The treatment of lymphedema. Cancer 1998; 83 (12, Suppl American): 2833-2834
  • 102 Blair SD, Wright DD, Backhouse CM, Riddle E, McCollum CN. Sustained compression and healing of chronic venous ulcers. BMJ 1988; 297 (6657): 1159-1161
  • 103 Trenell MI, Rooney KB, Sue CM, Thomspon CH. Compression garments and recovery from eccentric exercise: a (31)P-MRS study. J Sports Sci Med 2006; 5 (01) 106-114
  • 104 Kearon C, O'Donnell M. Graduated compression stockings to prevent venous thromboembolism in hospital: evidence from patients with acute stroke. Pol Arch Med Wewn 2011; 121 (1-2): 40-43
  • 105 Gandhi DB, Palmar JR, Lewis B, Schraibman IG. Clinical comparison of elastic supports for venous diseases of the lower limb. Postgrad Med J 1984; 60 (703) 349-352
  • 106 Lawrence D, Kakkar VV. Graduated, static, external compression of the lower limb: a physiological assessment. Br J Surg 1980; 67 (02) 119-121
  • 107 O'Donnell Jr TF, Rosenthal DA, Callow AD, Ledig BL. Effect of elastic compression on venous hemodynamics in postphlebitic limbs. JAMA 1979; 242 (25) 2766-2768
  • 108 Sachdeva A, Dalton M, Amaragiri SV, Lees T. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev 2010; (07) CD001484
  • 109 Bochmann RP, Seibel W, Haase E, Hietschold V, Rödel H, Deussen A. External compression increases forearm perfusion. J Appl Physiol (1985) 2005; 99 (06) 2337-2344
  • 110 Benkö T, Cooke EA, McNally MA, Mollan RA. Graduated compression stockings: knee length or thigh length. Clin Orthop Relat Res 2001; (383) 197-203
  • 111 Ali A, Caine MP, Snow BG. Graduated compression stockings: physiological and perceptual responses during and after exercise. J Sports Sci 2007; 25 (04) 413-419
  • 112 Brophy-Williams N, Driller MW, Shing CM, Fell JW, Halson SL. Confounding compression: the effects of posture, sizing and garment type on measured interface pressure in sports compression clothing. J Sports Sci 2015; 33 (13) 1403-1410
  • 113 Sigel B, Edelstein AL, Savitch L, Hasty JH, Felix Jr WR. Type of compression for reducing venous stasis. A study of lower extremities during inactive recumbency. Arch Surg 1975; 110 (02) 171-175
  • 114 Duffield R, Edge J, Merrells R. , et al. The effects of compression garments on intermittent exercise performance and recovery on consecutive days. Int J Sports Physiol Perform 2008; 3 (04) 454-468
  • 115 Kraemer WJ, Bush JA, Wickham RB. , et al. Influence of compression therapy on symptoms following soft tissue injury from maximal eccentric exercise. J Orthop Sports Phys Ther 2001; 31 (06) 282-290
  • 116 Zaleski AL, Ballard KD, Pescatello LS. , et al. The effect of compression socks worn during a marathon on hemostatic balance. Phys Sportsmed 2015; 43 (04) 336-341
  • 117 Zadow EK, Adams MJ, Wu SSX. , et al. Compression socks and the effects on coagulation and fibrinolytic activation during marathon running. Eur J Appl Physiol 2018; 118 (10) 2171-2177
  • 118 Sumann G, Fries D, Griesmacher A. , et al. Blood coagulation activation and fibrinolysis during a downhill marathon run. Blood Coagul Fibrinolysis 2007; 18 (05) 435-440
  • 119 Parker BA, Augeri AL, Capizzi JA. , et al. Effect of marathon run and air travel on pre- and post-run soluble D-dimer, microparticle procoagulant activity, and p-selectin levels. Am J Cardiol 2012; 109 (10) 1521-1525
  • 120 Zaleski AL, Pescatello LS, Thompson PD, Taylor BA. Protective effect of compression socks in a marathon runner with a genetic predisposition to thrombophilia due to Factor V Leiden. Phys Sportsmed 2015; 43 (03) 324-327
  • 121 Allaart CF, Poort SR, Rosendaal FR, Reitsma PH, Bertina RM, Briët E. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 1993; 341 (8838): 134-138
  • 122 Tait RC, Walker ID, Reitsma PH. , et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost 1995; 73 (01) 87-93
  • 123 Gandrille S, Borgel D, Ireland H. , et al; For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Protein S deficiency: a database of mutations. Thromb Haemost 1997; 77 (06) 1201-1214
  • 124 Lane DA, Mannucci PM, Bauer KA. , et al. Inherited thrombophilia: Part 1. Thromb Haemost 1996; 76 (05) 651-662
  • 125 Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353 (9159): 1167-1173
  • 126 De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood 1996; 87 (09) 3531-3544
  • 127 van der Meer FJ, Koster T, Vandenbroucke JP, Briët E, Rosendaal FR. The Leiden Thrombophilia Study (LETS). Thromb Haemost 1997; 78 (01) 631-635
  • 128 Monroe DM, Hoffman M, Roberts HR. Transmission of a procoagulant signal from tissue factor-bearing cell to platelets. Blood Coagul Fibrinolysis 1996; 7 (04) 459-464
  • 129 Díaz-Ricart M, Estebanell E, Lozano M. , et al. Thrombin facilitates primary platelet adhesion onto vascular surfaces in the absence of plasma adhesive proteins: studies under flow conditions. Haematologica 2000; 85 (03) 280-288
  • 130 Hultin MB. Modulation of thrombin-mediated activation of factor VIII:C by calcium ions, phospholipid, and platelets. Blood 1985; 66 (01) 53-58
  • 131 Hoffman M, Monroe III DM. A cell-based model of hemostasis. Thromb Haemost 2001; 85 (06) 958-965